BioSante Pharmaceuticals (BPAX) Announces Results for Phase Ib Clinical Study GVAX Pancreas Cancer Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. CRWV
2. SMCI
3. GAMI
4. LITE
5. SPY
6. ONON
7. CAVA
8. CSCO
9. ETOR
10. USO

Go back to BioSante Pharmaceuticals (BPAX) Announces Results for Phase Ib Clinical Study GVAX Pancreas Cancer Vaccine
BIOSANTE PHARM (NASDAQ: BPAX) Delayed: 1.09 --0 (-0%)
Previous Close $1.09    52 Week High $2.20 
Open $1.09    52 Week Low $0.80 
Day High $1.09    P/E N/A 
Day Low $1.09    EPS $-0.85 
Volume 2,100